18FDG PET/CT in the early assessment of non-small cell lung cancer response to immunotherapy: frequency and clinical significance of atypical evolutive patterns

Olivier Humbert,N. Cadour,Marie Paquet,Renaud Schiappa,M. Poudenx,D. Chardin,D. Borchiellini,D. Benisvy,M.J. Ouvrier,C. Zwarthoed,A. Schiazza,Marius Ilie,H. Ghalloussi,P. M. Koulibaly,Jacques Darcourt,J Otto

18FDG PET/CT in the early assessment of non-small cell lung cancer response to immunotherapy: frequency and clinical significance of atypical evolutive patterns

2019

Olivier Humbert
N. Cadour
Marie Paquet
Renaud Schiappa
M. Poudenx
D. Chardin
D. Borchiellini
D. Benisvy
M.J. Ouvrier
C. Zwarthoed
A. Schiazza
Marius Ilie
H. Ghalloussi
P. M. Koulibaly
Jacques Darcourt
J Otto

Purpose This prospective study aimed (1) to assess the non-small cell lung cancer (NSCLC) evolutive patterns to immunotherapy using FDG-PET and (2) to describe their association with clinical outcome.

Keywords:

Immunotherapy
Prospective cohort study
PET-CT
Clinical significance
Radiology
Medicine
Lung cancer
non small cell
Pembrolizumab
Stable Disease
Nivolumab
Oncology
Progressive disease
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations